Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
good news. Humana medicare lowered tier starting this month. Humana blocked GV. Vascepa only 8 percent more expensive than GV. No coupons allowed with GV. No GV available in Florida as of now.
According to Vascepa rep, difference in price is 8 percent
Just watch. Trump is laughing his ass off right now. The main concern will be the riots.
You don’t present top secret evidence to the lower courts This is very sensitive
They even introduced it on fox business.
Get a popcorn
Democracy at Stake: @SidneyPowell1 @TomFitton discuss the potential for nationwide voter irregularities & whether state legislatures and courts will uphold the rule of law. #MAGA #AmericaFirst #Dobbs pic.twitter.com/srJFNAaVA7
— Lou Dobbs (@LouDobbs) November 6, 2020
What amarin needs to do is to get hands on generic capsule and send it for testing.
Do you think i work for FDA?
Are you blaming me? I understand percentages
I remember from med school: generics can be off by 20 percent.
The market for vascepa is huge. Way more than 10 million. Now remember we have 6 or 7 different statins. They all made money. Lipitor, zocor, crestor, pravachol etc. There is only one Vascepa. Plus any generics.
The ACS guidelines refer to lipid guidelines as IIa recommendation.
If you see you don’t see a statin in those tables. But we use lipitor as soon as we diagnose ACS.
Did you press acute coronary syndrome guidelines? Yes.
This was listed in those guidelines and not lipid guidelines. It is in the same document, subtitle does not matter.
We have other subtitles such a antiplatelets, antithrombotic agents etc.
management of lipids is part of these guidelines
Whenever someone has an MI, we automatically put them on a high dose statin usually lipitor 80mg. That is part of out initial medication setup, ofter entered while a patient is still in the ER.
So you are incorrect
Yes. Google European society of cardiology guidlelines
No generics in europe
European society of cardiology includes vascepa as a part of acute coronary syndrome protocol. That means each patient that walks in to a hospital with heart attack gets Vascepa as a part of protocol. That is huge.
Used to live in Herring for a year
That is one word i learned. And “brod”. Lol. I never tried. Where do you live?
North
No private message
You have enough risk factors
I suggest you do carotid ultrasound to see if there is potential carotid disease
And even better if you can do calcium score and even better coronary CTA.
Given that you have type 1 diabets, i am sure these 2 tests will identify some artherosclerotic plaque.
Showing them evidence of plaque will ensure they have no choice but to approve it.
I agree but the fda will never do that
Btw i always stop both
No overlap based on triglycerides cutoffs
Marine more than 500
Reduce it up to 500
My point is lovaza and vascepa are used for 2 different things. Should FDA ban fenofibrates? Gemfibrozil? These are triglyceride therapies.
Lovaza is effective for triglyceride reduction. Better than Vascepa in that matter. People with triglycerides over 500 may disagree with you.
Generic lovaza is legitimate drug used to lower triglycerides and there is nothing amarin can do
Ok. So they are doing AG before patent expiration? I think they are undercutting Merck’s hep c drug
Hep C gilead drugs are not generic
To approve Pcsk9 is. way harder than vascepa. It is pain in the ass. Insurances do not like paying for pcsk9.
Nobody prescribes brand lovaza. Generic lovaza is $30.
Nobody is suing anybody. Patients are usually clueless. They prefer less medications and less out of pocket costs.
Vascepa is not SOC yet. But again, patients have no clue.
Vascepa reduce it label got approved in December 2019
Insurances change their formularies in November. Bit too late for 2020. Let’s hope 2021 gets better coverage.
Because if insurances. Will get better next year
It is the insurances not amarin. Trust me.
There is prevalence of disease
Trigs above 500: 1 percent of US population
Patients with reduce it indication: the highest prevalence of all diseases, above cancer.
Logic says if hikma indends to play by the book and not infrige RiT patents, then there would be no need to erase GV PR. But maybe eating too much goulash makes logical things illogical.
This was a medical conference presentation submitted months ago. It has noting to do with amarin.
They did but ADA guidlines are weak influence.
You need ACC AHA ones for medication sales to pick up
Yes every few years. Not sure how often
Cardiologists
They basically care GDMT (guideline directed medical therapy) for which ACC/AHA guideline has strongest power.
There you go. You got it.
Not sure when is the next guidline update
Not in ACC/AHA guidelines
Vascepa is mostly prescribed by cardiologists. Cardiologist are always guidleline driven. Vascepa is not on ACC or AHA guidleliness.
Well vascepa is not on ACC/AHA guidlines
That’s what counts
Because vascepa is not part of any guidlelines. It is not standard of care. Yet.